Magic mushrooms and other psychedelic drugs should be reclassified as “a matter of urgency” to support clinical research into medical and therapeutic treatment, a group of influential MPs have said.
A report by the home affairs committee said there was a “growing body of evidence” that suggests psychedelics – and psilocybin in particular – may have therapeutic benefits, including treating depression and PTSD.
